STE PRINCE PHARMA SARL — Erythromycin Importer Profile
Pharmaceutical Importer · #12 buyer for Erythromycin · $627.5K import value · 30 shipments · CONGO D REPULIC · DGFT Verified
STE PRINCE PHARMA SARL is the #12 importer of Erythromycin from India with $627.5K in import value and 30 verified shipments. STE PRINCE PHARMA SARL holds a 0.8% market share in Erythromycin imports based in CONGO D REPULIC. The company sources from 2 verified suppliers across 14 formulations shipped to 4 countries. Overall, STE PRINCE PHARMA SARL imports 8 pharmaceutical products worth $6.3M across 5 therapeutic categories.
STE PRINCE PHARMA SARL — Erythromycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Erythromycin to STE PRINCE PHARMA SARL?
Verified from 30 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PRASHI PHARMA PRIVATE LIMITED | $353.4K | 20 | 56.3% |
| VIDACARE MEDICA PRIVATE LIMITED | $274.1K | 10 | 43.7% |
STE PRINCE PHARMA SARL sources Erythromycin from 2 verified Indian suppliers based on 30 customs records. The primary supplier is PRASHI PHARMA PRIVATE LIMITED accounting for 56.3% of imports.
How Does STE PRINCE PHARMA SARL Compare to Nearest Erythromycin Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | VIATRIS NEW ZEALAND | NEW ZEALAND | $901.7K | 33 | $27.3K |
| 7 | SBR GROUP OF COMPANIES | LIBERIA | $800.0K | 16 | $50.0K |
| 12 | STE PRINCE PHARMA SARL ★ | CONGO | $634.3K | 30 | $21.1K |
| 15 | NOUMED LIFE SCIENCES LIMITED | UNITED KINGDOM | $474.9K | 12 | $39.6K |
| 2 | NELPA LIFESCIENCES INC | PHILIPPINES | $450.0K | 9 | $50.0K |
STE PRINCE PHARMA SARL ranks #12 among 992 Erythromycin importers from India. Average shipment value of $21.1K compared to the market average of $8.6K. The closest competitors by value are VIATRIS NEW ZEALAND and SBR GROUP OF COMPANIES.
Where Does STE PRINCE PHARMA SARL Import Erythromycin To?
Destination countries from 30 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CONGO D REPULIC | $256.4K | 9 | 40.9% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $205.2K | 13 | 32.7% |
| CONGO | $148.2K | 7 | 23.6% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $17.7K | 1 | 2.8% |
STE PRINCE PHARMA SARL imports Erythromycin to 4 countries. The primary destination is CONGO D REPULIC receiving 40.9% of shipments worth $256.4K.
What Erythromycin Formulations Does STE PRINCE PHARMA SARL Import?
| Formulation | Value | Shipments |
|---|---|---|
| DAVITHRO- 500 TABLETS EACH FILM COATEDTABLET CONTAINS :ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 500MG | $138.5K | 6 |
| DAVITHRO- 500 TABLETS EACH FILM COATED TABLET CONTAINS :ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 500 MG | $76.7K | 2 |
| DAVITHRO- 500 TABLETS EACH FILM COATED TABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 500MG | $69.4K | 2 |
| DAVITHRO- 250 TABLETS EACH FILM COATED TABLET CONTAINS :ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 250 MG | $57.0K | 3 |
| DAVITHRO- 500 TABLETS EACH FILM COATED TABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 500 MG | $50.0K | 1 |
| DAVITHRO- 250 TABLETS EACH FILM COATED TABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 250 MG | $40.3K | 2 |
| DAVITHRO- 250 TABLETS EACH FILM COATEDTABLET CONTAINS :ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 250MG | $37.6K | 4 |
| DAVITHRO- 250 TABLETS EACH FILM COATEDTABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 250MG | $35.7K | 2 |
| DAVITHRO- 500 TABLETS EACH FILM COATEDTABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO, ERYTHROMYCIN B.P. 500MG | $33.3K | 1 |
| DAVITHRO- 250 TABLETS EACH FILM COATED TABLET CONTAINS : ERYTHROMYCIN STERATE B.P.EQIV.TO ERYTHROMYCIN B.P. 250MGNOS | $29.1K | 3 |
STE PRINCE PHARMA SARL imports 14 distinct Erythromycin formulations from India. The top formulation is DAVITHRO- 500 TABLETS EACH FILM COATEDTABLET CONTAINS :ERYT with 6 shipments worth $138.5K.
Who Are the Top Buyers of Erythromycin from India and How Much Does STE PRINCE PHARMA SARL Import?
India exported $8.5M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. STE PRINCE PHARMA SARL imports $627.5K of this total, accounting for 0.8% of India's Erythromycin exports with 30 shipments from CONGO D REPULIC. This is verified from 30 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for STE PRINCE PHARMA SARL's Erythromycin Imports?
STE PRINCE PHARMA SARL's average Erythromycin order value is $20.9K per consignment, based on 30 shipments totaling $627.5K. STE PRINCE PHARMA SARL is based in CONGO D REPULIC and ranks #12 among all Erythromycin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Erythromycin to STE PRINCE PHARMA SARL?
STE PRINCE PHARMA SARL sources Erythromycin from 2 verified Indian suppliers: PRASHI PHARMA PRIVATE LIMITED ($353.4K, 56.3%), VIDACARE MEDICA PRIVATE LIMITED ($274.1K, 43.7%). This is based on 30 customs records.
How Does STE PRINCE PHARMA SARL Compare to Other Erythromycin Importers?
STE PRINCE PHARMA SARL ranks #12 among 992 Erythromycin importers from India with a 0.8% market share. The top 3 importers are ACE HEALTH CARE LDA ($1.2M), MYLAN AUSTRALIA PTY LIMITED ($1.1M), LIFESCIENCE LOGISTICS ($989.1K). STE PRINCE PHARMA SARL processed 30 shipments from CONGO D REPULIC.
What Other Antibiotics Products Does STE PRINCE PHARMA SARL Import?
STE PRINCE PHARMA SARL also imports these antibiotics products. Each links to the detailed product page.
About STE PRINCE PHARMA SARL
STE PRINCE PHARMA SARL imports 8 products worth $6.3M. Beyond Erythromycin, top products include Tetracycline, Caffeine, Metronidazole, Griseofulvin, Mebendazole. View the complete STE PRINCE PHARMA SARL profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: STE PRINCE PHARMA SARL matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as STE PRINCE PHARMA SARL's capped import value divided by total capped export value for Erythromycin across all Indian exporters.
- 5.Verified Records: This page is backed by 30 individual customs records matching STE PRINCE PHARMA SARL importing Erythromycin, covering 14 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Import Data for STE PRINCE PHARMA SARL
Access order-level details, pricing data, supplier connections, and competitive analysis for STE PRINCE PHARMA SARL's Erythromycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
STE PRINCE PHARMA SARL
Full Company Profile →
8 products · $6.3M total trade · 5 categories
STE PRINCE PHARMA SARL × Erythromycin
Verified from customs records
Company Overview
Top Products by STE PRINCE PHARMA SARL
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for STE PRINCE PHARMA SARL.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current order-level data, contact TransData Nexus.